NB
Nitin Bhausaheb Satpute
About Nitin Bhausaheb Satpute
Data last updated:
Nitin Bhausaheb Satpute has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Ranikem Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Ranikem Pharmaceuticals Private Limited at ₹24 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ranikem Pharmaceuticals Private Limited U51909MH2022PTC386251 | Director | 07 Jul 2022 | 2022 | ₹24 Lakh (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nitin Bhausaheb Satpute
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nitin Bhausaheb Satpute
Nitin Bhausaheb Satpute has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Ranikem Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Ranikem Pharmaceuticals Private Limited at ₹24 Lakh (FY 2025).
Nitin Bhausaheb Satpute is associated with 1 company as Director, including Ranikem Pharmaceuticals Private Limited (₹24 Lakh).
Nitin Bhausaheb Satpute has expertise in General Business.
Nitin Bhausaheb Satpute has 4 years in corporate governance.
By reported revenue, the largest current company of Nitin Bhausaheb Satpute is Ranikem Pharmaceuticals Private Limited, with revenue of ₹24 Lakh (FY 2025).
Nitin Bhausaheb Satpute currently holds positions at 1 company: Ranikem Pharmaceuticals Private Limited (₹24 Lakh).